Try our beta test site
27 studies found for:    Open Studies | "Goiter"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Goiter" (27 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance
Condition: Goiter
Intervention: Drug: Levothyroxine
2 Recruiting Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Sertoli-Leydig Cell Tumor of Ovary;   Medulloepithelioma;   Embryonal Rhabdomyosarcoma of Cervix;   Goiter;   Sarcoma;   Pineoblastoma;   Pituitary Tumors;   Wilms Tumor
Intervention:
3 Recruiting Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
Conditions: Graves Disease;   Graves Ophthalmopathy;   Graves' Ophthalmopathy Worsened
Interventions: Drug: Antithyroid Drug;   Procedure: Total thyroidectomy
4 Not yet recruiting HIFU vs RAI in the Relapsed Graves' Disease
Condition: Graves Disease
Intervention: Device: Echopulse
5 Recruiting Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Conditions: Thyrotoxicosis;   Graves Disease;   Thyroiditis
Intervention:
6 Recruiting ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy
Condition: Graves Disease
Intervention: Biological: ATX-GD-59
7 Recruiting K1-70 - A Study in Subjects With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: K1-70 intramuscular
8 Recruiting Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans
Conditions: Hyperthyroidism;   Tomography;   Emission-Computed;   Single-Photon
Intervention:
9 Recruiting A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: CFZ533
10 Recruiting Thyroid Disease and Personality Study
Condition: Graves' Disease
Intervention: Procedure: blood sampling
11 Recruiting D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
Condition: Graves' Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
12 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
13 Recruiting Post-Radioiodine Graves' Management: The PRAGMA-Study
Condition: Graves' Disease
Intervention:
14 Recruiting The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
Condition: Mild Graves' Ophthalmopathy
Interventions: Drug: Metformin;   Drug: Placebo
15 Recruiting mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)
Condition: Dysthyroid Ophthalmopathies
Intervention:
16 Recruiting Rituximab (RTX) Therapy in Patients With Active TAO
Condition: Ophthalmopathy, Thyroid-Associated
Interventions: Drug: Rituximab;   Drug: Iv Methylprednisolone;   Drug: peroral methylprednisolone and Methotrexate
17 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
18 Recruiting Celecoxib for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Celecoxib;   Drug: artificial tears
19 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Methylprednisolone + ASTED;   Drug: Methylprednisolone +Placebo
20 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
Condition: Thyroid Eye Disease
Interventions: Drug: ASTED;   Dietary Supplement: Selenium;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.